Cargando…

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

BACKGROUND: Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel disease (IBD). METHODS: This study was a prospective, observational, multicentre study. Overall, 286 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Carl, Rundquist, Sara, Lykiardopoulos, Vyron, Udumyan, Ruzan, Karlén, Per, Grip, Olof, Söderman, Charlotte, Almer, Sven, Hertervig, Erik, Marsal, Jan, Gunnarsson, Jenny, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Öberg, David, Bergemalm, Daniel, Hjortswang, Henrik, Halfvarson, Jonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255566/ https://www.ncbi.nlm.nih.gov/pubmed/34276808 http://dx.doi.org/10.1177/17562848211023386

Ejemplares similares

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
por: Visuri, Isabella, et al.
Publicado: (2023)

Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
por: Thunberg, Joel, et al.
Publicado: (2022)

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
por: Bergqvist, Viktoria, et al.
Publicado: (2017)

Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders †
por: Haglund, Sofie, et al.
Publicado: (2023)

Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers
por: Rundquist, Sara, et al.
Publicado: (2020)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

Prognostic Biosignatures at Ileocecal Resection: Hope or Reality?
por: Salomon, Benita, et al.
Publicado: (2021)

Temperature measurements with a temporal scanner: systematic review and meta-analysis
por: Geijer, Håkan, et al.
Publicado: (2016)

Hospital admission with pneumonia and subsequent persistent risk of chronic kidney disease: national cohort study
por: Sundin, Per-Ola, et al.
Publicado: (2018)

Erratum to: Grip strength modifies the association between estimated glomerular filtration rate and all-cause mortality
por: Sundin, Per-Ola, et al.
Publicado: (2019)

Grip strength modifies the association between estimated glomerular filtration rate and all-cause mortality
por: Sundin, Per-Ola, et al.
Publicado: (2019)

The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study
por: Holmgren, Johanna, et al.
Publicado: (2022)

Stress resilience and physical fitness in adolescence and risk of coronary heart disease in middle age
por: Bergh, Cecilia, et al.
Publicado: (2015)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study
por: Zwicker, Stephanie, et al.
Publicado: (2017)

Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay
por: Vande Casteele, Niels, et al.
Publicado: (2023)

Real‐world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
por: Bergqvist, Viktoria, et al.
Publicado: (2022)

Stress resilience in male adolescents and subsequent stroke risk: cohort study
por: Bergh, Cecilia, et al.
Publicado: (2014)

Elevated fecal peptidase D at onset of colitis in Galphai2(-/-) mice, a mouse model of IBD
por: Bergemalm, Daniel, et al.
Publicado: (2017)

Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility
por: Söderman, Jan, et al.
Publicado: (2015)

Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease
por: Norén, Elisabeth, et al.
Publicado: (2017)

Inverse and Concordant Mucosal Pathway Gene Expressions in Inflamed and Non-Inflamed Ulcerative Colitis Patients: Potential Relevance to Aetiology and Pathogenesis
por: Söderman, Jan, et al.
Publicado: (2022)

FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice
por: Bosma, Madeleen, et al.
Publicado: (2016)

Mortality following unemployment during an economic downturn: Swedish register-based cohort study
por: Montgomery, Scott, et al.
Publicado: (2013)

Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management
por: Meehan, Adrian D., et al.
Publicado: (2017)

Validity of Routinely Collected Swedish Data in the International Enhanced Recovery After Surgery (ERAS) Database
por: Xu, Yin, et al.
Publicado: (2021)

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
por: Bergqvist, Viktoria, et al.
Publicado: (2018)

Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease
por: Forss, Anders, et al.
Publicado: (2022)

Acne in late adolescence and risk of prostate cancer
por: Ugge, Henrik, et al.
Publicado: (2017)

Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease
por: Juzenas, Simonas, et al.
Publicado: (2022)

Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study
por: Bennet, Louise, et al.
Publicado: (2020)

Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease – Novel Clues to Drug Targets and Disease Mechanisms?
por: Haglund, Sofie, et al.
Publicado: (2013)

Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells – Effects on gene expression levels and thiopurine metabolism
por: Haglund, Sofie, et al.
Publicado: (2017)

Inflammatory bowel disease registries for collection of patient iron parameters in Europe
por: Halfvarson, Jonas, et al.
Publicado: (2018)

Vedolizumab-Associated Hypereosinophilia and Hepatoxicity
por: De Marco, Davide, et al.
Publicado: (2022)

Genetic Variation and Gene Expression Levels of Tight Junction Genes Indicates Relationships Between PTEN as well as MAGI1 and Microscopic Colitis
por: Norén, Elisabeth, et al.
Publicado: (2017)

Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study
por: Gunnarsson, M., et al.
Publicado: (2015)

Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
por: Andersson, Erik, et al.
Publicado: (2017)

Vedolizumab in the treatment of Crohn’s disease of the pouch
por: Khan, Freeha, et al.
Publicado: (2018)

Vedolizumab for chronic antibiotic-refractory pouchitis
por: Singh, Amandeep, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3h4dbagr2drrfrh9tsir4l6eip